The Deal
Sunday, November 22, 
8:14 pm

CME sweetens Nymex bid for shareholders

  Share     E-Mail    Discussion    Print Story

CME Group Inc. "sweetened" its bid for Nymex Holdings Inc. with a share buyback of $1.1 billion in stock over the next 18 months and the issuance of a $5 a share dividend if its bid succeeds. Last week the $8.2 billion deal between CME and Nymex won the approval of antitrust regulators.

Continue reading below

Also on Dealscape

The last hurdle for CME is a group of dissident Nymex shareholders that have been pushing to increase the deal above $115 a share. The original value of the transaction was around $11 billion, but the stock of both companies has quickly deteriorated since January due to conditions in the financial markets.

Dissident shareholders such as Cataldo Capozza also have lawsuits pending against the deal. Capozza said he will try to block the deal in its current state and is also considering a move to remove the energy exchange's CEO, James Newsome. - Maria Woehr

See CME, Nymex win Justice OK
See CME, Nymex refile merger proposal





Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.